Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SCIENCE A new study predicts half of all children in North and South America will be…
Op-Eds
No Beef in Meat Packaging Controversy
Yet another potential food scare is being manufactured out of thin air — or rather out of carbon monoxide. Last November, with little fanfare,…
Op-Eds
The Lancet Pricks Itself
The term “medical journals” elicits automatic respect from most people. Not from me: I read them. I've found the editors to be increasingly…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. SAFETY Congress considers legislation to standardize food labeling and safety warnings. CEI Expert…
Op-Eds
WTO and Biotech Food: Who Really Won?
The long-awaited World Trade Organization decision on biotechnology applied to agricultural products, finally released earlier this month, elicited a great deal of buzz…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. FINANCE A new report finds executives at mortgage lender Fannie Mae responsible for an…